BJC Capital Advisors is an investment banking firm with an exclusive focus on the earlier-stage companies in the biopharmaceutical industry.  We offer an integrated set of professional services tailored specifically to the unique needs of sector participants intended to optimize transaction outcomes.

Representative Transactions

Area of Expertise: Targeted Indications

BJC Capital Advisors has been involved in transactions across a broad array of disease indications including:

• ​allergy and autoimmune disorders
• cardio-renal
• endocrine/metabolic
• immunological disorders
• infectious diseases
• gastrointestinal
• neurodegenerative disorders
• neurological - pain management
• neurological - addiction disorders
• oncology
• ophthalmology
• orthopedic
• precision medicine
• rare disease
• specialty pharmaceuticals

Area of Expertise: Therapeutic Treatment Modalities

Our engagements have spanned drugs and drug candidates utilizing a breadth of treatment modalities.  Transaction experience has involved numerous therapeutic technologies including:  

• autologous/allogeneic cell therapy
• antibody drug conjugates (ADCs)
• compounded pharmaceuticals
• gene editing technologies
• gene therapy
• monoclonal antibody technology
• novel delivery technologies
• small molecule
• vaccine technologies